BGBarbara Gentilin

Barbara Gentilin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Barbara Gentilin has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • A. M. Baffico

    E.O. Ospedali Galliera, S.C. Laboratorio di Genetica, Genova, Italy

    1 shared publication
  • C. Izzi

    Spedali Civili di Brescia, U.O. Diagnosi Prenatale, Dipartimento Ostetrico‐Ginecologico, Brescia, Italy

    1 shared publication
  • C. Rodriguez‐Perez

    Spedali Civili di Brescia, U.O. Neonatologia, Brescia, Italy

    1 shared publication
  • Donatella Quagliarini

    UOS di Diagnosi Prenatale, Clinica Ostetrica e Ginecologica I IRCCS Cà Granda Ospedale Maggiore Policlinico, via della Commenda 12, 20122, Milano, Italy

    1 shared publication
  • E. Grosso

    AOU S. Giovanni Battista ‐ SCDU Genetica Medica, Torino, Italy

    1 shared publication
  • E. Viora

    AO OIRM, S. Anna ‐ SC Ecografia e Diagnosi Prenatale, Torino, Italy

    1 shared publication

Latest Publications

  • Open Access

    Early manifestations in a cohort of children prenatally diagnosed with 47,XYY. Role of multidisciplinary counseling for parental guidance and prevention of aggressive behavior

    by Faustina Lalatta, Emanuela Folliero, Ugo Cavallari, Marina Di Segni, Barbara Gentilin, Roberto Fogliani, Donatella Quagliarini, Paola Vizziello, Federico Monti, Luigi Gargantini

    An increasing number of foetuses are recognized as having double Y because of the widespread use of prenatal screening using chorionic villus sampling and amniocentesis. 47, XYY karyotype occurs in about one out of 1,000 newborn males, but it is not often detected unless it is diagnosed during prenatal testing. Despite the fact that unbiased follow-up studies demonstrate largely normal post-natal development of young men with 47, XYY, there is a scarcity of controlled studies about the neurological, cognitive and behavioural phenotype which remains the main reason for anxiety and anticipatory negative attitudes of parents. Furthermore, prejudices still exist among professionals and the general population concerning the relationship between this sex chromosome aneuploidy and aggressive and antisocial behaviours.


  • Open Access

    Phenotype of five cases of prenatally diagnosed campomelic dysplasia harboring novel mutations of the SOX9 gene

    by B. Gentilin, F. Forzano, M. F. Bedeschi, T. Rizzuti, F. Faravelli, C. Izzi, M. Lituania, C. Rodriguez‐Perez, M. P. Bondioni, G. Savoldi, et al.

    Objectives: Campomelic dysplasia is a rare congenital skeletal disorder characterized by bowing of the long bones and a variety of other skeletal and extraskeletal defects, many of which can now be identified prenatally using advanced ultrasound equipment. The disorder is caused by mutations in SRY‐box 9 (SOX9), a gene that is abundantly expressed in chondrocytes as well as in other tissues. However, the correlation between genotype and phenotype is still unclear. We report five cases of prenatally detected campomelic dysplasia in which the diagnosis was confirmed by molecular analysis.Methods: Ultrasound examinations were performed between 12 and 32 weeks. Standard fetal biometric measurements were obtained. Fetal sex was determined sonographically and confirmed by chromosomal analysis. Genomic DNA was obtained in four cases before termination of pregnancy from chorionic villi or amniocytes and in one case postnatally from peripheral blood.Results: Skeletal dysplasia, most often limb shortening and bowed femora, was observed in one case in the first trimester, in three cases in the second trimester and in one case, presenting late for antenatal care, in the third trimester. Four of the pregnancies were terminated and one was carried to term. Postmortem/postnatal physical and radiographic examinations confirmed the presence of anomalies characteristic of campomelic dysplasia. A de novo mutation in the SOX9 gene was detected in all four cases that underwent termination. The father of the proband in the case that went to term was a carrier of a somatic mosaic mutation without clinical or radiographic signs of campomelic dysplasia.Conclusions: It is likely that the integrated expertise of ultrasonographers, obstetricians, pediatricians and clinical geneticists will markedly improve the likelihood of accurate prenatal clinical diagnoses of campomelic dysplasia. This will, in turn, encourage more specific molecular testing and facilitate comprehensive genetic counseling. Copyright © 2010 ISUOG. Published by John Wiley & Sons, Ltd.